A neurotoxic cryptic peptide arising from TDP-43-dependent cryptic splicing of PKN1.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41720774.
- Also identified by DOI 10.1038/s41467-026-68916-0 and PMC identifier 13035944.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dysfunction of transactive response DNA-binding protein 43 (TDP-43) drives neurodegeneration in amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD), in part through inducing aberrant RNA splicing. However, whether such mis-splicing yields stable, pathogenic proteins remains unclear. Here, we identify a TDP-43-repressed cryptic exon in Protein kinase N1 (PKN1), designated PKN1-5a1, which is activated in ALS patient brains and introduces a premature termination codon. This aberrant transcript escapes nonsense-mediated decay and is translated into a truncated peptide, PKN1-N207 (PKN207), detectable in AD brains with TDP-43 pathology. In mice, PKN207 impairs cognition, memory, and synaptic plasticity. Our findings demonstrate that TDP-43 loss-induced cryptic splicing can generate stable neurotoxic polypeptides, revealing a peptide-mediated mechanism in TDP-43 proteinopathies.
Medical subject headings
- DNA-Binding Proteins
- RNA Splicing
- Amyotrophic Lateral Sclerosis
- Alzheimer Disease
- Peptides
- Protein Kinase C